1 Pashtoon M. Kasi, MD, MS, Weill Cornell Medicine, Meyer Cancer Center, Englander Institute of Precision Medicine, New York-Presbyterian Hospital, New York, NY; Gordon Fehringer, PhD and Alexey Aleshin, MD, Natera Inc, Austin, TX; and Scott Kopetz, MD, PhD, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.